| 1 |
Cavallini M, Gazzola R, Metalla M, et al. The role of hyaluronidase in the treatment of complications from hyaluronic acid dermal fillers. Aesthet Surg J 2013;33:1167-74.
DOI
|
| 2 |
Dunn AL, Heavner JE, Racz G, et al. Hyaluronidase: a review of approved formulations, indications and off-label use in chronic pain management. Expert Opin Biol Ther 2010;10:127-31.
DOI
|
| 3 |
Mio K, Carrette O, Maibach HI, et al. Evidence that the serum inhibitor of hyaluronidase may be a member of the inter-alpha-inhibitor family. J Biol Chem 2000;275:32413-21.
DOI
|
| 4 |
Mio K, Stern R. Inhibitors of the hyaluronidases. Matrix Biol 2002;21:31-7.
DOI
|
| 5 |
DeLorenzi C. Transarterial degradation of hyaluronic acid filler by hyaluronidase. Dermatol Surg 2014;40:832-41.
DOI
|
webmaster
